Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 197-198

  Fulda, Simone ^a,b   Fichtner, Iduna ^a   Hero, Barbara ^b   Berthold, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Etoposide; Hyperthermia; Neuroblastoma

Indexed keywords

ETOPOSIDE;

CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; NEUROBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; ETOPOSIDE; HEAT; HUMANS; HYPERTHERMIA, INDUCED; NEUROBLASTOMA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0035171142     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<197::AID-MPO1047>3.0.CO;2-5     Document Type: Conference Paper

References (7)

1. Hyperthermia and drags
2. Reduction od etoposide induced cell killing by hyperthermia can occur without changes in etoposide transport or DNA topoisomerase II activity
3. Hyperthermia, thermotolerance and topoisomerase II inhibitors
4. Thermostability of cytostatic drugs in vitro and thermosensitivity of cultured human lymphoblasts against cytostatic drugs
5. Flow cytometric analysis of nuclear matrix proteins: Method and patential applications
6. Interaction of hyperthermia and chemotherapy
7. Enhanced expression of DANN topoisomerase II gene in respomse to heat shock stress in human epidermoid cancer KB lines